Now showing items 1-1 of 1

    • Aducanumab Therapy to Treat Alzheimer's Disease: A Narrative Review 

      Beshir, Semira Abdi; Aadithsoorya, A. M.; Parveen, Affana; Goh, Sheron Sir Loon; Hussain, Nadia; Menon, Vineetha Bharathan (Hindawi Limited, 2022)
      Background. Aducanumab, a new monoclonal antibody that targets β-amyloid aggregates, has been granted conditional approval by the U.S. FDA for treatment of mild Alzheimer's disease (AD). The approval of this drug without ...